Asher Rajkumar Rajan on Muck Rack

Asher Rajkumar Rajan

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Asher Rajkumar

Contact Asher Rajkumar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis - Oncogene

|
By Asher Rajkumar Rajan, Glen Kristiansen, Bhopal C Mohapatra, Hamid Band
| Nature Verified
Abstract Androgen receptor (AR)-mediated signaling is essential for PC tumorigenesis. In the TCGA database we observed a positive correlation between ECD and AR expression. Consistently, Dihydrotestosterone (DHT) treatment of PC cell lines increased ECD mRNA and protein levels, and AR knockdown (KD) reduced ECD expression.
Open in Who Shared Issue with article?

ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis

|
By Mohsin Raza, Asher Rajkumar Rajan, Benjamin Kennedy, Timothy E Reznicek
| biorxiv.org
Abstract Androgen receptor (AR)-mediated signaling is essential for PC tumorigenesis. In TCGA database we observed a positive correlation between ECD and AR expression. Consistently, Dihydrotestosterone (DHT) treatment of PC cell lines increased ECD mRNA and protein levels, and AR knockdown (KD) reduced ECD expression.
Open in Who Shared Issue with article?

ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysis

|
By Benjamin Kennedy, Mohsin Raza, Sameer Mirza, Asher Rajkumar Rajan
| biorxiv.org
Abstract The ecdysoneless (ECD) mRNA and protein are overexpressed in breast cancer (BC), and its overexpression correlates with poor prognosis and short patient survival, particularly in ERBB2/HER2-positive BC. This study investigates the co-operative oncogenic mechanism of ECD and ERBB2 by deriving transgenic mice overexpressing ECD and/or ERBB2 (huHER2) in mammary epithelium under MMTV promoter, as well as human mammary immortal epithelial cell lines (hMECs) overexpressing ECD and/or ERBB2.
Open in Who Shared Issue with article?
See all 4 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified